Mateus Bond Boghossian
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Mateus Bond Boghossian has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Eduardo Guimarães Hourneaux de Moura
Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
9 shared publications - Igor Braga Ribeiro
Gastrointestinal Endoscopy Unit, Hospital das Clínicas, University of Sao Paulo School of Medicine, São Paulo, Brazil
4 shared publications - Epifanio Silvino Do Monte Junior
Hospital das Clínicas, University of São Paulo School of Medicine, Gastroenterology, São Paulo, Brazil
3 shared publications - Mateus Pereira Funari
Universidade de São Paulo, Faculty of Medicine, Hospital das Clínicas, Endoscopy Unit - São Paulo (SP), Brazil
3 shared publications - Bruno Salomão Hirsch
Universidade de São Paulo, Brasil
2 shared publications Gustavo de Oliveira Luz
Gastrointestinal Endoscopy Unit, Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
2 shared publications
Latest Publications
- Open Access
- 7 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 13 (CP) , a26812538
Transoral incisionless fundoplication for patients with gastroesophageal reflux disease after peroral endoscopic myotomy: Prospective cohort
Achalasia is a condition related to failure of relaxation of the lower esophageal sphincter (LES). Treatment is based on reducing LES pressure. Although treatment is traditionally surgical, poor candidates for this modality may be treated with peroral endoscopic myotomy (POEM). However, POEM is associated with a relatively high incidence of gastroesophageal reflux disease (GERD). For cases refractory to proton pump inhibitors (PPIs), transoral incisionless fundoplication (TIF) is one of the endoscopic therapies proposed.This was a pilot single-center prospective cohort study including 10 patients with post-POEM GERD refractory to clinical management who underwent endoscopic treatment with the TIF procedure between February and November 2021. We included patients ≥ 18 years old who developed GERD after POEM.Technical success was achieved in all 10 cases treated with TIF. In 6- and 12-month follow-up, seven patients (70%) reduced PPI use. Two patients (20%) had no esophagitis initially, increasing to five (55%) at 6 months and four (44%) at 12 months. Symptom evaluation and GERD-HRQL questionnaire showed a significant score reduction at 6 months and a downward trend at 12 months. Mean Eckardt score showed a decreasing trend, although mean dysphagia score showed a slight tendency to increase in 1 year. The procedure was considered safe, with no adverse events.Use of TIF seems to be a feasible alternative for treating GERD after POEM, improving both clinical and endoscopic parameters and pHmetry in a considerable percentage of cases.
- 7 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 13 (CP) , a26812538
Open AccessTransoral incisionless fundoplication for patients with gastroesophageal reflux disease after peroral endoscopic myotomy: Prospective cohort
Achalasia is a condition related to failure of relaxation of the lower esophageal sphincter (LES). Treatment is based on reducing LES pressure. Although treatment is traditionally surgical, poor candidates for this modality may be treated with peroral endoscopic myotomy (POEM). However, POEM is associated with a relatively high incidence of gastroesophageal reflux disease (GERD). For cases refractory to proton pump inhibitors (PPIs), transoral incisionless fundoplication (TIF) is one of the endoscopic therapies proposed.This was a pilot single-center prospective cohort study including 10 patients with post-POEM GERD refractory to clinical management who underwent endoscopic treatment with the TIF procedure between February and November 2021. We included patients ≥ 18 years old who developed GERD after POEM.Technical success was achieved in all 10 cases treated with TIF. In 6- and 12-month follow-up, seven patients (70%) reduced PPI use. Two patients (20%) had no esophagitis initially, increasing to five (55%) at 6 months and four (44%) at 12 months. Symptom evaluation and GERD-HRQL questionnaire showed a significant score reduction at 6 months and a downward trend at 12 months. Mean Eckardt score showed a decreasing trend, although mean dysphagia score showed a slight tendency to increase in 1 year. The procedure was considered safe, with no adverse events.Use of TIF seems to be a feasible alternative for treating GERD after POEM, improving both clinical and endoscopic parameters and pHmetry in a considerable percentage of cases.
- Open Access
- 24 August 2022
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (S 02) , E1022-E1023
Modified endoscopic vacuum therapy for hypopharyngeal acute leakage after foreign body perforation
Conventional endoscopic vacuum therapy is currently used worldwide to treat esophageal leaks, with a healing rate of 67 %–100 % [1] [2]. The vacuum effect works through its effect on important mechanisms such as micro and macro deformation, tissue reperfusion, exudate control, and bacterial clearance [3]. Modified endoscopic vacuum therapy (MEVT) has some benefits when compared with the conventional technique, such as lower costs, less adherence, the requirement for fewer exchanges, and a shorter procedural duration [2]. In addition, it can be easily performed [4]. Although there were no reported cases of the use of hypopharyngeal vacuum therapy, we report a hypopharyngeal leak that was successfully treated with MEVT, leading to a new possibility when faced with hypopharyngeal defects. A 42-year-old man came to the emergency room with progressive dysphagia 24 hours after eating food that included a piece of bone. A computed tomography (CT) scan detected a foreign body measuring 3.2 × 1.1 cm at the hypopharynx. Orotracheal intubation by bronchoscopy was indicated. Subsequently, the patient underwent endoscopic foreign body removal ([Fig. 1]); on reviewing the mucosa, we noted signs of perforation ([Fig. 2]). Therefore, MEVT was performed ([Fig. 3]; [Video 1]). The patient remained intubated for 5 days, during which time he received MEVT, antibiotics, and corticosteroids. After this period, a new bronchoscopy was performed, which demonstrated improvement of the edema of the hypopharynx, and the patient was extubated. Video 1 Endoscopy vacuum therapy is performed in the management of a hypopharyngeal leak caused by a perforation that was identified after endoscopic removal of a foreign body. The patient progressively improved in terms of his clinical and laboratory parameters. He was evaluated by the otorhinolaryngology team after 8 days and a swallowing video-endoscopy was performed. This evaluation visualized complete velopharyngeal closure, the presence of salivary stasis, and preserved mobility, so his diet was upgraded to an oral homogeneous intake with a paste-like consistency. Endoscopic re-evaluation after 1 month demonstrated a white scar, with no signs of stenosis or other complications ([Fig. 4]). Outpatient follow-up demonstrated good tolerance of a regular diet, and the patient did not report any complaints. Endoscopy_UCTN_Code_TTT_1AQ_2AG Article published online: 24 August 2022 © 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 24 August 2022
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (S 02) , E1022-E1023
Open AccessModified endoscopic vacuum therapy for hypopharyngeal acute leakage after foreign body perforation
Conventional endoscopic vacuum therapy is currently used worldwide to treat esophageal leaks, with a healing rate of 67 %–100 % [1] [2]. The vacuum effect works through its effect on important mechanisms such as micro and macro deformation, tissue reperfusion, exudate control, and bacterial clearance [3]. Modified endoscopic vacuum therapy (MEVT) has some benefits when compared with the conventional technique, such as lower costs, less adherence, the requirement for fewer exchanges, and a shorter procedural duration [2]. In addition, it can be easily performed [4]. Although there were no reported cases of the use of hypopharyngeal vacuum therapy, we report a hypopharyngeal leak that was successfully treated with MEVT, leading to a new possibility when faced with hypopharyngeal defects. A 42-year-old man came to the emergency room with progressive dysphagia 24 hours after eating food that included a piece of bone. A computed tomography (CT) scan detected a foreign body measuring 3.2 × 1.1 cm at the hypopharynx. Orotracheal intubation by bronchoscopy was indicated. Subsequently, the patient underwent endoscopic foreign body removal ([Fig. 1]); on reviewing the mucosa, we noted signs of perforation ([Fig. 2]). Therefore, MEVT was performed ([Fig. 3]; [Video 1]). The patient remained intubated for 5 days, during which time he received MEVT, antibiotics, and corticosteroids. After this period, a new bronchoscopy was performed, which demonstrated improvement of the edema of the hypopharynx, and the patient was extubated. Video 1 Endoscopy vacuum therapy is performed in the management of a hypopharyngeal leak caused by a perforation that was identified after endoscopic removal of a foreign body. The patient progressively improved in terms of his clinical and laboratory parameters. He was evaluated by the otorhinolaryngology team after 8 days and a swallowing video-endoscopy was performed. This evaluation visualized complete velopharyngeal closure, the presence of salivary stasis, and preserved mobility, so his diet was upgraded to an oral homogeneous intake with a paste-like consistency. Endoscopic re-evaluation after 1 month demonstrated a white scar, with no signs of stenosis or other complications ([Fig. 4]). Outpatient follow-up demonstrated good tolerance of a regular diet, and the patient did not report any complaints. Endoscopy_UCTN_Code_TTT_1AQ_2AG Article published online: 24 August 2022 © 2022. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 20 August 2021
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (12) , 6413-6426
Endoscopic resection of esophageal and gastric submucosal tumors from the muscularis propria layer: submucosal tunneling endoscopic resection versus endoscopic submucosal excavation: A systematic review and meta-analysis
Background Submucosal tunneling endoscopic resection (STER) and endoscopic submucosal excavation (ESE) are less-invasive therapeutic alternatives to surgical resection for the removal of esophageal or gastric submucosal tumors (SMTs). This study aimed to comparing STER versus ESE for the resection of esophageal and gastric SMTs from the muscularis propria. Methods This systematic review and meta-analysis was reported in accordance with PRISMA guidelines through December 2020. Pooled outcome measures included complete resection, en bloc resection, bleeding, perforation, adverse events, recurrence, procedure duration, and length of hospital stay. Risk ratio (RR) and mean difference (MD) was calculated as well as Peto time-to-event analyses to determine recurrence rate. Results Five retrospective cohort studies (n = 269 STER versus n = 319 ESE) were included. There was no difference in rates of complete resection [RR: 1.01 (95% CI 0.94, 1.07)], en bloc resection [RR: 0.95 (95% CI 0.84, 1.08)], recurrence [OR: 1.18 (95% CI 0.33, 4.16)], and total adverse events [RR: 1.33 (95% CI 0.78, 2.27)]. Specific adverse events including rates of perforation [RR: 0.57 (95% CI 0.12, 2.74)] and bleeding [RR: 1.21 (95% CI 0.30, 4.88)] were not different between STER and ESE. There was a statistical difference when evaluating procedure time, with the STER group presenting significantly larger values [MD: 24.62 min (95% CI 20.04, 29.20)]. Conclusion STER and ESE were associated with similar efficacy and safety; however, ESE was associated with a significantly decreased time to complete the procedure.
- 20 August 2021
- Published by Springer Nature in Surgical Endoscopy
- Vol. 35 (12) , 6413-6426
Endoscopic resection of esophageal and gastric submucosal tumors from the muscularis propria layer: submucosal tunneling endoscopic resection versus endoscopic submucosal excavation: A systematic review and meta-analysis
Background Submucosal tunneling endoscopic resection (STER) and endoscopic submucosal excavation (ESE) are less-invasive therapeutic alternatives to surgical resection for the removal of esophageal or gastric submucosal tumors (SMTs). This study aimed to comparing STER versus ESE for the resection of esophageal and gastric SMTs from the muscularis propria. Methods This systematic review and meta-analysis was reported in accordance with PRISMA guidelines through December 2020. Pooled outcome measures included complete resection, en bloc resection, bleeding, perforation, adverse events, recurrence, procedure duration, and length of hospital stay. Risk ratio (RR) and mean difference (MD) was calculated as well as Peto time-to-event analyses to determine recurrence rate. Results Five retrospective cohort studies (n = 269 STER versus n = 319 ESE) were included. There was no difference in rates of complete resection [RR: 1.01 (95% CI 0.94, 1.07)], en bloc resection [RR: 0.95 (95% CI 0.84, 1.08)], recurrence [OR: 1.18 (95% CI 0.33, 4.16)], and total adverse events [RR: 1.33 (95% CI 0.78, 2.27)]. Specific adverse events including rates of perforation [RR: 0.57 (95% CI 0.12, 2.74)] and bleeding [RR: 1.21 (95% CI 0.30, 4.88)] were not different between STER and ESE. There was a statistical difference when evaluating procedure time, with the STER group presenting significantly larger values [MD: 24.62 min (95% CI 20.04, 29.20)]. Conclusion STER and ESE were associated with similar efficacy and safety; however, ESE was associated with a significantly decreased time to complete the procedure.
- 9 August 2021
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (07) , E376-E377
Low-cost modified endoscopic vacuum therapy using a triple-lumen tube allows nutrition and drainage for treatment of an early post–bariatric surgery leak
Leaks after laparoscopic sleeve gastrectomy (LSG) occur in up to 5 % of patients, with mortality rates approaching 4 % [1]. Among available therapies for leaks after bariatric surgery, endoscopic approaches have been shown to be safe and effective. Tissue sealants, cap-mounted clips, suturing, stents, a cardiac septal defect occluder, septotomy, endoscopic internal drainage with double pigtails, and endoscopic vacuum therapy (EVT) are the forefront of the therapeutic endoscopic arsenal [2] [3]. However, an individualized approach is needed to determine the best endoscopic treatment strategy for a given patient. In this video, we describe the successful treatment of a LSG leak using low-cost modified EVT. A 30-year-old woman with class II obesity developed fever, nausea, and abdominal pain 14 days after LSG. Computed tomographic scan revealed a leak associated with a small contained collection adjacent to the staple line of the proximal stomach (angle of His). Underwater esophagogastroduodenoscopy was performed without air insufflation to avoid disrupting the collection ([Fig. 1]). The patient was treated with modified EVT using widely available triple-lumen tubing to allow for nutrition using the jejunal tube and EVT using the fenestrated portion of the tube ([Video 1]). The procedure was well tolerated and the patient remained on enteral nutrition as well as taking a liquid diet on the day following the procedure. External drainage was not required. After 15 days, imaging demonstrated resolution of the leak ([Fig. 2]), and the modified EVT system was removed ([Fig. 3]). Video 1 Low-cost modified endoscopic vacuum therapy with a triple-lumen tube. In summary, endoscopic drainage with this low-cost, modified EVT is a highly effective and safe technique for leaks [4] [5]. Furthermore, EVT obviates the need for external drainage and employs widely available materials. Ultimately, this low-cost modified EVT allows for nutrition and drainage with a single tube through the nares, enabling decreased procedure times, longer periods between EVT system exchanges, and fewer adverse events. Endoscopy_UCTN_Code_TTT_1AO_2AI Publication Date: 09 August 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 9 August 2021
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (07) , E376-E377
Low-cost modified endoscopic vacuum therapy using a triple-lumen tube allows nutrition and drainage for treatment of an early post–bariatric surgery leak
Leaks after laparoscopic sleeve gastrectomy (LSG) occur in up to 5 % of patients, with mortality rates approaching 4 % [1]. Among available therapies for leaks after bariatric surgery, endoscopic approaches have been shown to be safe and effective. Tissue sealants, cap-mounted clips, suturing, stents, a cardiac septal defect occluder, septotomy, endoscopic internal drainage with double pigtails, and endoscopic vacuum therapy (EVT) are the forefront of the therapeutic endoscopic arsenal [2] [3]. However, an individualized approach is needed to determine the best endoscopic treatment strategy for a given patient. In this video, we describe the successful treatment of a LSG leak using low-cost modified EVT. A 30-year-old woman with class II obesity developed fever, nausea, and abdominal pain 14 days after LSG. Computed tomographic scan revealed a leak associated with a small contained collection adjacent to the staple line of the proximal stomach (angle of His). Underwater esophagogastroduodenoscopy was performed without air insufflation to avoid disrupting the collection ([Fig. 1]). The patient was treated with modified EVT using widely available triple-lumen tubing to allow for nutrition using the jejunal tube and EVT using the fenestrated portion of the tube ([Video 1]). The procedure was well tolerated and the patient remained on enteral nutrition as well as taking a liquid diet on the day following the procedure. External drainage was not required. After 15 days, imaging demonstrated resolution of the leak ([Fig. 2]), and the modified EVT system was removed ([Fig. 3]). Video 1 Low-cost modified endoscopic vacuum therapy with a triple-lumen tube. In summary, endoscopic drainage with this low-cost, modified EVT is a highly effective and safe technique for leaks [4] [5]. Furthermore, EVT obviates the need for external drainage and employs widely available materials. Ultimately, this low-cost modified EVT allows for nutrition and drainage with a single tube through the nares, enabling decreased procedure times, longer periods between EVT system exchanges, and fewer adverse events. Endoscopy_UCTN_Code_TTT_1AO_2AI Publication Date: 09 August 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- Top Cited Papers
- 14 June 2021
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 406 (6) , 1803-1817
EUS-guided gastroenterostomy versus duodenal stent placement and surgical gastrojejunostomy for the palliation of malignant gastric outlet obstruction: a systematic review and meta-analysis
Purpose Malignant gastric outlet obstruction (GOO) is associated with significant morbidity and decreased quality of life, thereby necessitating effective and safe palliative treatment. As such, we sought to compare endoscopic ultrasound-guided gastroenterostomy (EUS-GE) versus duodenal stent (DS) placement and surgical gastrojejunostomy (SGJ) for palliation of malignant GOO. Methods Searches of electronic databases were performed to identify studies comparing EUS-GE versus DS and/or SGJ for palliative treatment of GOO. Outcomes included technical and clinical success, severe adverse events (SAEs), rate of stent obstruction (including tumor ingrowth), length of hospital stay (LOS), reintervention, and 30-day all-cause mortality. Differences in dichotomous and continuous outcomes were reported as risk difference and mean difference, respectively. Results Seven studies (n = 513 patients) were included. When compared to DS placement, EUS-GE was associated with a higher clinical success, fewer SAEs, decreased stent obstruction, lower rate of tumor ingrowth, and decreased need for reintervention. Compared to SGJ, EUS-GE was associated with a lower technical success; however, LOS was significantly decreased. All other outcomes including clinical success, SAEs, reintervention rate, and 30-day mortality were not significantly different between an EUS-guided versus surgical approach. Conclusions EUS-GE was associated with significantly improved outcomes compared to DS placement for palliative treatment of malignant GOO. Despite SGJ possessing a higher technical success compared to EUS-GE, LOS was significantly longer with no difference in clinical success or rate of adverse events.
- 14 June 2021
- Published by Springer Nature in Langenbeck's Archives of Surgery
- Vol. 406 (6) , 1803-1817
Top Cited PapersEUS-guided gastroenterostomy versus duodenal stent placement and surgical gastrojejunostomy for the palliation of malignant gastric outlet obstruction: a systematic review and meta-analysis
Purpose Malignant gastric outlet obstruction (GOO) is associated with significant morbidity and decreased quality of life, thereby necessitating effective and safe palliative treatment. As such, we sought to compare endoscopic ultrasound-guided gastroenterostomy (EUS-GE) versus duodenal stent (DS) placement and surgical gastrojejunostomy (SGJ) for palliation of malignant GOO. Methods Searches of electronic databases were performed to identify studies comparing EUS-GE versus DS and/or SGJ for palliative treatment of GOO. Outcomes included technical and clinical success, severe adverse events (SAEs), rate of stent obstruction (including tumor ingrowth), length of hospital stay (LOS), reintervention, and 30-day all-cause mortality. Differences in dichotomous and continuous outcomes were reported as risk difference and mean difference, respectively. Results Seven studies (n = 513 patients) were included. When compared to DS placement, EUS-GE was associated with a higher clinical success, fewer SAEs, decreased stent obstruction, lower rate of tumor ingrowth, and decreased need for reintervention. Compared to SGJ, EUS-GE was associated with a lower technical success; however, LOS was significantly decreased. All other outcomes including clinical success, SAEs, reintervention rate, and 30-day mortality were not significantly different between an EUS-guided versus surgical approach. Conclusions EUS-GE was associated with significantly improved outcomes compared to DS placement for palliative treatment of malignant GOO. Despite SGJ possessing a higher technical success compared to EUS-GE, LOS was significantly longer with no difference in clinical success or rate of adverse events.
- 16 April 2021
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (03) , E127-E128
Long-term endoscopic follow-up after closure of a post-bariatric surgery fistula with a cardiac septal defect occluder
Bariatric surgery is currently the most effective treatment strategy for obesity; however, post-surgical fistulas may occur in up to 8.3 % of patients following traditional Roux-en-Y gastric bypass (RYGB) [1]. Currently endoscopic treatment of these complications remains challenging, with unsuccessful fistula closure occurring in 20 % of patients [1] [2]. More recently, the use of a cardiac septal defect occluder (CSDO) device has been proposed as a novel treatment for the closure of gastrointestinal fistulas. A CSDO is a double-disc self-expanding closure device made of nitinol and interwoven polyester. The successful use of CSDOs in the management of gastrointestinal surgical and bariatric leaks has been reported; however, there are limited data regarding long-term outcomes [3] [4]. In this video, we describe the successful closure of a gastrocutaneous fistula using a CSDO and demonstrate persistent closure at long-term follow-up ([Video 1]). Video 1 Long-term follow-up of successful gastrocutaneous fistula closure using a cardiac septal defect occluder. A 36-year-old man with a history of RYGB 3 years previously presented to our institution with a gastrocutaneous fistula. Initial treatment with a fully covered self-expandable metal stent (SEMS) was unsuccessful, and the patient subsequently underwent treatment with a CSDO [5]. The CSDO procedure was immediately successful with closure of the gastrocutaneous fistula and, at 1-year follow-up, endoscopy demonstrated an intact, well-positioned CSDO, with no evidence of a fistula ([Fig. 1 a]). At 3-year follow-up, routine endoscopy did not identify the CSDO ([Fig. 1 b]). An upper gastrointestinal contrast study was performed and confirmed that the CSDO was not present in the gastrointestinal lumen or intra-abdominal cavity ([Fig. 2]). Despite the presumed migration of the device, the fistula remained closed with no recurrent fistula or leakage noted. In summary, the use of a CSDO device appears to be a safe and effective long-term treatment for patients with post-surgical gastrocutaneous fistulas. While more data are needed to verify these results, CSDOs may be a feasible alternative for gastrointestinal leaks and fistulas that are refractory to traditional endoscopic techniques. Endoscopy_UCTN_Code_TTT_1AO_2AI Publication Date: 16 April 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 16 April 2021
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (03) , E127-E128
Long-term endoscopic follow-up after closure of a post-bariatric surgery fistula with a cardiac septal defect occluder
Bariatric surgery is currently the most effective treatment strategy for obesity; however, post-surgical fistulas may occur in up to 8.3 % of patients following traditional Roux-en-Y gastric bypass (RYGB) [1]. Currently endoscopic treatment of these complications remains challenging, with unsuccessful fistula closure occurring in 20 % of patients [1] [2]. More recently, the use of a cardiac septal defect occluder (CSDO) device has been proposed as a novel treatment for the closure of gastrointestinal fistulas. A CSDO is a double-disc self-expanding closure device made of nitinol and interwoven polyester. The successful use of CSDOs in the management of gastrointestinal surgical and bariatric leaks has been reported; however, there are limited data regarding long-term outcomes [3] [4]. In this video, we describe the successful closure of a gastrocutaneous fistula using a CSDO and demonstrate persistent closure at long-term follow-up ([Video 1]). Video 1 Long-term follow-up of successful gastrocutaneous fistula closure using a cardiac septal defect occluder. A 36-year-old man with a history of RYGB 3 years previously presented to our institution with a gastrocutaneous fistula. Initial treatment with a fully covered self-expandable metal stent (SEMS) was unsuccessful, and the patient subsequently underwent treatment with a CSDO [5]. The CSDO procedure was immediately successful with closure of the gastrocutaneous fistula and, at 1-year follow-up, endoscopy demonstrated an intact, well-positioned CSDO, with no evidence of a fistula ([Fig. 1 a]). At 3-year follow-up, routine endoscopy did not identify the CSDO ([Fig. 1 b]). An upper gastrointestinal contrast study was performed and confirmed that the CSDO was not present in the gastrointestinal lumen or intra-abdominal cavity ([Fig. 2]). Despite the presumed migration of the device, the fistula remained closed with no recurrent fistula or leakage noted. In summary, the use of a CSDO device appears to be a safe and effective long-term treatment for patients with post-surgical gastrocutaneous fistulas. While more data are needed to verify these results, CSDOs may be a feasible alternative for gastrointestinal leaks and fistulas that are refractory to traditional endoscopic techniques. Endoscopy_UCTN_Code_TTT_1AO_2AI Publication Date: 16 April 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 19 February 2021
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (01) , E38-E39
Endoscopic septotomy for fistula after bariatric surgery
Gastric fistula following bariatric surgery is a complication with considerable morbidity and mortality [1] [2]. After Roux-en-Y gastric bypass (RYGB), the gastric pouch may develop a chronic fistula and the formation of a perigastric cavity bounded by a septum. The altered anatomy chronically elevates the intraluminal pressure, impairing emptying of the perigastric cavity and perpetuating the fistula [3]. Endoscopic septotomy is a minimally invasive technique for cutting the septum. The goals are ensuring adequate patency of the perigastric cavity, decreasing its pressure, and draining the fistula [1] [4] [5]. A 67-year-old woman underwent a RYGB (body mass index: 48 kg/m² before, 25 kg/m² after). She developed a gastrocutaneous fistula, which was unsuccessfully treated with a long-term nasoenteric tube. Eight months after RYGB, she was referred for endoscopic assessment ([Video 1]). Sutures were identified in the greater curvature of the gastric pouch. They were removed with endoscopic scissors and a perigastric cavity (bounded by a septum) with a fistula orifice in it was identified. The fistula orifice was initially treated with argon plasma coagulation and a guidewire was externalized through the fistula’s cutaneous orifice ([Fig. 1]), with placement of a 7-Fr double-pigtail stent in the fistula tract. After 3 months, the gastrocutaneous leak was reduced but not resolved. We removed the pigtail, performed a septotomy with an IT knife, and placed an esophageal fully covered (28 × 160 mm) self-expandable metal stent. The proximal end of the stent was fixed by endosuture to avoid migration. After 1 week, the stent was removed and the patient was able to take a soft diet. Four weeks later, the cutaneous fistula orifice was closed ([Fig. 2]) and esophagogastroduodenoscopy confirmed closure of the fistula’s gastric orifice ([Fig. 3]). At 3 weeks’ follow-up, the patient was asymptomatic and doing well on a regular diet. Video 1 Complex fistulas after bariatric surgery require challenging endoscopic management. We report a case of bariatric surgery complicated by gastrocutaneous fistula, which was successfully treated with endoscopic septotomy. Endoscopy_UCTN_Code_CPL_1AH_2AG Publication Date: 19 February 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 19 February 2021
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 54 (01) , E38-E39
Endoscopic septotomy for fistula after bariatric surgery
Gastric fistula following bariatric surgery is a complication with considerable morbidity and mortality [1] [2]. After Roux-en-Y gastric bypass (RYGB), the gastric pouch may develop a chronic fistula and the formation of a perigastric cavity bounded by a septum. The altered anatomy chronically elevates the intraluminal pressure, impairing emptying of the perigastric cavity and perpetuating the fistula [3]. Endoscopic septotomy is a minimally invasive technique for cutting the septum. The goals are ensuring adequate patency of the perigastric cavity, decreasing its pressure, and draining the fistula [1] [4] [5]. A 67-year-old woman underwent a RYGB (body mass index: 48 kg/m² before, 25 kg/m² after). She developed a gastrocutaneous fistula, which was unsuccessfully treated with a long-term nasoenteric tube. Eight months after RYGB, she was referred for endoscopic assessment ([Video 1]). Sutures were identified in the greater curvature of the gastric pouch. They were removed with endoscopic scissors and a perigastric cavity (bounded by a septum) with a fistula orifice in it was identified. The fistula orifice was initially treated with argon plasma coagulation and a guidewire was externalized through the fistula’s cutaneous orifice ([Fig. 1]), with placement of a 7-Fr double-pigtail stent in the fistula tract. After 3 months, the gastrocutaneous leak was reduced but not resolved. We removed the pigtail, performed a septotomy with an IT knife, and placed an esophageal fully covered (28 × 160 mm) self-expandable metal stent. The proximal end of the stent was fixed by endosuture to avoid migration. After 1 week, the stent was removed and the patient was able to take a soft diet. Four weeks later, the cutaneous fistula orifice was closed ([Fig. 2]) and esophagogastroduodenoscopy confirmed closure of the fistula’s gastric orifice ([Fig. 3]). At 3 weeks’ follow-up, the patient was asymptomatic and doing well on a regular diet. Video 1 Complex fistulas after bariatric surgery require challenging endoscopic management. We report a case of bariatric surgery complicated by gastrocutaneous fistula, which was successfully treated with endoscopic septotomy. Endoscopy_UCTN_Code_CPL_1AH_2AG Publication Date: 19 February 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 17 February 2021
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 53 (12) , C12
Correction: Acute esophageal necrosis (black esophagus) with active upper gastrointestinal bleeding: What to do?
Publication Date: 17 February 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 17 February 2021
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 53 (12) , C12
Correction: Acute esophageal necrosis (black esophagus) with active upper gastrointestinal bleeding: What to do?
Publication Date: 17 February 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 4 February 2021
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 53 (12) , E468-E469
Acute esophageal necrosis (black esophagus) with active upper gastrointestinal bleeding: What to do?
Black esophagus is a rare syndrome with a measured incidence of about 0.01 to 0.28 % of the population, with very few reports in the literature [1]. Although rare, mortality reaches 30 % of cases [2]. The main predisposing factors include male gender, old age, cardiovascular diseases, ischemic diseases, and thromboembolic diseases [3]. A 72-year-old man was admitted to the intensive care unit owing to pneumonia with sepsis and hemodynamic instability using noradrenaline. An upper gastrointestinal endoscopy exam was performed because of massive upper gastrointestinal bleeding. On examination, a black esophagus with mucosal detachment and exposure of the muscular layer was found in about 75 % of the organ lumen, which extended 20 cm from the upper dental arch to the esophagogastric transition. Voluminous active bleeding was also observed ([Fig. 1]). We decided to use an esophageal fully covered self-expandable metal stent by the “over-the-wire” technique for the purpose of hemostasis ([Fig. 2], [Video 1]). Video 1 We demonstrate a case of a black esophagus with upper gastrointestinal bleeding treated unusually with a fully covered self-expandable metal stent for hemostasis purposes. After the 12-hour procedure, the patient was stable and without vasoactive drugs. Another upper gastrointestinal endoscopy was performed 72 hours later, which demonstrated success in achieving hemostasis and, after stent removal, the organ's surface showed no bleeding or signs of perforation ([Fig. 3]). Black esophagus has no indication for stent use [4]. Because of active bleeding in this case, however, it saved the life of the patient, who was discharged from the intensive care unit after 7 days of hospitalization. We emphasize that in these cases the patient tends to progress to a distal esophageal stricture, and early dilation is the key to successful treatment [2] [5]. Endoscopy_UCTN_Code_TTT_1AO_2AD Publication Date: 04 February 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 4 February 2021
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 53 (12) , E468-E469
Acute esophageal necrosis (black esophagus) with active upper gastrointestinal bleeding: What to do?
Black esophagus is a rare syndrome with a measured incidence of about 0.01 to 0.28 % of the population, with very few reports in the literature [1]. Although rare, mortality reaches 30 % of cases [2]. The main predisposing factors include male gender, old age, cardiovascular diseases, ischemic diseases, and thromboembolic diseases [3]. A 72-year-old man was admitted to the intensive care unit owing to pneumonia with sepsis and hemodynamic instability using noradrenaline. An upper gastrointestinal endoscopy exam was performed because of massive upper gastrointestinal bleeding. On examination, a black esophagus with mucosal detachment and exposure of the muscular layer was found in about 75 % of the organ lumen, which extended 20 cm from the upper dental arch to the esophagogastric transition. Voluminous active bleeding was also observed ([Fig. 1]). We decided to use an esophageal fully covered self-expandable metal stent by the “over-the-wire” technique for the purpose of hemostasis ([Fig. 2], [Video 1]). Video 1 We demonstrate a case of a black esophagus with upper gastrointestinal bleeding treated unusually with a fully covered self-expandable metal stent for hemostasis purposes. After the 12-hour procedure, the patient was stable and without vasoactive drugs. Another upper gastrointestinal endoscopy was performed 72 hours later, which demonstrated success in achieving hemostasis and, after stent removal, the organ's surface showed no bleeding or signs of perforation ([Fig. 3]). Black esophagus has no indication for stent use [4]. Because of active bleeding in this case, however, it saved the life of the patient, who was discharged from the intensive care unit after 7 days of hospitalization. We emphasize that in these cases the patient tends to progress to a distal esophageal stricture, and early dilation is the key to successful treatment [2] [5]. Endoscopy_UCTN_Code_TTT_1AO_2AD Publication Date: 04 February 2021 (online) © 2021. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany